Clinical Study of the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in People Aged 65 Years or Older
Clinical trial NCT00765076 · COMPLETED
Trial details
- NCT number
- NCT00765076
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-16
- Primary completion
- 2009-12-04
- Enrollment
- 192
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.